To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC2864 | Jtk-853 |
Novel nonnucleoside inhibitor of the hepatitis C virus RNA-dependent RNA polymerase
More description
|
|
| DCC2863 | Jte-607 |
Cytokine release inhibitor, inhibiting production of IL-1ß, IL-8, IL-6, IL-10 and TNFalpha
More description
|
|
| DCC2862 | Jte-151 |
Novel RORγ
More description
|
|
| DCC2861 | Jsi287 |
Novel ERK inhibitor, alleviating IMQ-induced mice skin lesions through ERK/IL-17 signaling pathway
More description
|
|
| DCC2860 | Jsf-2513 |
Novel potent antitubercular agent, inhibiting InhA and FAS-II pathway
More description
|
|
| DCC2859 | Jsf-2019 |
Novel antitubercular agent, inhibiting InhA and FAS-II pathway
More description
|
|
| DCC2858 | Js399-19 |
Novel specific inhibitor of Fusarium myosin I; Fungicide
More description
|
|
| DCC2857 | Jrc-ii-191 |
Novel inhibitor of CD4-gp120 binding, blocking the binding of the HIV-1 envelope glycoprotein gp120 to the CD4 receptor
More description
|
|
| DCC2856 | Jra-003 |
Novel selective inhibitor of nuclear translocation of IKKα as the most potent synthetic gibberellin against cancer-derived cell lines, displaying no cytotoxicity in cells derived from noncancerous sources (HEK 293T, HS 578BST, HS 888Lu, HS 895Sk, HUVEC)
More description
|
|
| DCC2855 | Jr-220 |
Non-toxic anti-relapse agent, acamprosate
More description
|
|
| DCC2854 | Jp4-039 |
Non-toxic radioprotector GS-nitroxide, improving hematopoiesis in long-term bone marrow cultures (LTBMCs)
More description
|
|
| DCC2853 | Jp1201 |
Novel SMAC mimetic, sensitizing non-small cell lung cancers to multiple chemotherapy agents in an IAP-dependent but TNF-α-independent manner
More description
|
|
| DCC2852 | Jns 1-40 |
Novel cysteine-reactive covalent ligand, selectively targeting C377 of PPP2R1A to impair breast cancer signaling, proliferation, and in vivo tumor growth
More description
|
|
| DCC2851 | Jnj-dgat2-b |
Selective DGAT2 inhibitor
More description
|
|
| DCC2850 | Jnj-dgat1-a |
Selective DGAT1 inhibitor
More description
|
|
| DCC2849 | Jnj-61432059 |
Novel TARP γ-8 Selective AMPAR Negative Modulator
More description
|
|
| DCC2848 | Jnj-53721590 |
Negative control for JNJ-54119936
More description
|
|
| DCC2847 | Jnj-49153390 |
Novel inhibitor of respiratory syncytial virus (RSV), binding the RSV F glycoprotein and inhibiting membrane fusion
More description
|
|
| DCC2846 | Jnj-42491293 |
Novel ago-PAM for the metabotropic glutamate receptor subtype 2 (mGluR2)
More description
|
|
| DCC2845 | Jnj-42396302 |
Novel inhibitor of PDE10A
More description
|
|
| DCC2844 | Jnj-40929837 |
Novel potent, orally active LTA4H inhibitor
More description
|
|
| DCC2843 | Jnj-40573663 |
Negaive control for JNJ-42396302
More description
|
|
| DCC2841 | Jnj-40264796 |
Negative control for JNJ-40068782
More description
|
|
| DCC2840 | Jnj-40255293 |
Novel Adenosine A 2A /A 1 Antagonist With Efficacy In Preclinical Models of Parkinson's Disease
More description
|
|
| DCC2839 | Jnj-40068782 |
Novel potent, selective, and systemically active positive allosteric modulator (PAM) of mGlu2-receptors
More description
|
|
| DCC2838 | Jnj-28583867 |
Histamine H3 receptor antagonist and serotonin reuptake inhibitor
More description
|
|
| DCC2837 | Jnj-28330835 |
Selective androgen receptor modulator with minimal prostate hypertrophic activity stimulating sexual behavior in female rats
More description
|
|
| DCC2836 | Jnj-26076713 |
Novel EthR inhibitor, boosting antituberculous activity of ethionamide
More description
|
|
| DCC2835 | Jnj-20788560 |
Selective delta opioid receptor agonist as a potent and efficacious antihyperalgesic agent
More description
|
|
| DCC2834 | Jnj-1930942 |
Novel Positive Allosteric Modulator of the α7 Nicotinic Acetylcholine Receptor
More description
|
|